Tendon properties in a mouse model of severe osteogenesis imperfecta

References

• Enderli TA, Burtch SR, Templet JN, Carriero A. Animal models of osteogenesis imperfecta: applications in clinical research. Orthop Res Rev. 2016;8:41–55. doi:10.2147/ORR.S85198.
   PubMedGoogle Scholar
• Takken T, Terlingen HC, Helders PJ, Pruijs H, der Ent CK V, Engelbert RH. 2004. Cardiopulmonary fitness and muscle strength in patients with osteogenesis imperfecta type I. J Pediatr. 145(6):813–818. doi:10.1016/j.jpeds.2004.08.003
   PubMed Web of Science ®Google Scholar
• Graf A, Hassani S, Krzak J, Caudill A, Flanagan A, Bajorunaite R, et al. Gait characteristics and functional assessment of children with type I osteogenesis imperfecta. J Orthop Res. 2009;27(9):1182–1190. doi:10.1002/jor.20871.
   PubMed Web of Science ®Google Scholar
• Veilleux LN, Lemay M, Pouliot-Laforte A, Cheung MS, Glorieux FH, Rauch F. 2014. Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I. J Clin Endocrinol Metab. 99(2):E356–62. doi:10.1210/jc.2013-3209
   PubMed Web of Science ®Google Scholar
• Veilleux LN, Darsaklis VB, Montpetit K, Glorieux FH, Rauch F. 2017. Muscle Function in Osteogenesis Imperfecta Type IV. Calcif Tissue Int. 101(4):362–370. doi:10.1007/s00223-017-0287-y
   PubMed Web of Science ®Google Scholar
• Moffatt P, Boraschi-Diaz I, Bardai G, Rauch F. Muscle transcriptome in mouse models of osteogenesis imperfecta. Bone. 2021;148:115940. doi:10.1016/j.bone.2021.115940.
   PubMed Web of Science ®Google Scholar
• Tauer JT, Rauch F. Novel ActRIIB ligand trap increases muscle mass and improves bone geometry in a mouse model of severe osteogenesis imperfecta. Bone. 2019;128:115036. doi:10.1016/j.bone.2019.115036.
   PubMed Web of Science ®Google Scholar
• Tauer JT, Rigo Canevazzi GH, Schiettekatte-Maltais J, Rauch F, Bergeron R, Veilleux LN. Muscle-bone properties after prolonged voluntary wheel running in a mouse model of dominant severe osteogenesis imperfecta. J Musculoskelet Neuronal Interact. 2021;21(4):517–527.
   PubMed Web of Science ®Google Scholar
• Tauer JT, Abdullah S, Rauch F. 2019. Effect of anti-tgf-beta treatment in a mouse model of severe osteogenesis imperfecta. J Bone Miner Res. 34(2):207–214. doi:10.1002/jbmr.3617
   PubMed Web of Science ®Google Scholar
• Oestreich AK, Carleton SM, Yao X, Gentry BA, Raw CE, Brown M, et al. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice. Osteoporos Int. 2016;27(1):161–170. doi:10.1007/s00198-015-3226-7.
   PubMed Web of Science ®Google Scholar
• Misof K, Landis WJ, Klaushofer K, Fratzl P. 1997. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest. 100(1):40–45. doi:10.1172/JCI119519
   PubMed Web of Science ®Google Scholar
• McBride DJ Jr., Choe V, Shapiro JR, Brodsky B. 1997. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol. 270(2):275–284. doi:10.1006/jmbi.1997.1106
   PubMed Web of Science ®Google Scholar
• Sims TJ, Miles CA, Bailey AJ, Camacho NP. Properties of collagen in OIM mouse tissues. Connect Tissue Res. 2003;44(1):202–205. doi:10.1080/03008200390181663. Suppl.
   PubMed Web of Science ®Google Scholar
• Chen F, Guo R, Itoh S, Moreno L, Rosenthal E, Zappitelli T, et al. First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome. J Bone Miner Res. 2014;29(6):1412–1423. doi:10.1002/jbmr.2177.
   PubMed Web of Science ®Google Scholar
• Miles CA, Sims TJ, Camacho NP, Bailey AJ. 2002. The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. J Mol Biol. 321(5):797–805. doi:10.1016/s0022-2836(02)00703-9
   PubMed Web of Science ®Google Scholar
• Chang SW, Shefelbine SJ, Buehler MJ. 2012. Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease. Biophys J. 102(3):640–648. doi:10.1016/j.bpj.2011.11.3999
   PubMed Web of Science ®Google Scholar
• Boraschi-Diaz I, Tauer JT, El-Rifai O, Guillemette D, Lefebvre G, Rauch F, et al. Metabolic phenotype in the mouse model of osteogenesis imperfecta. J Endocrinol. 2017;234(3):279–289. doi:10.1530/JOE-17-0335.
   PubMed Web of Science ®Google Scholar
• Tauer JT, Robinson ME, Rauch F. 2019. Osteogenesis Imperfecta: new Perspectives from Clinical and Translational Research. JBMR plus. 3(8):e10174. doi:10.1002/jbm4.10174
   PubMedGoogle Scholar
• Tran PHT, Skrba T, Wondimu E, Galatioto G, Svensson RB, Olesen AT, et al. The influence of fibrillin-1 and physical activity upon tendon tissue morphology and mechanical properties in mice. Physiol Rep. 2019;7(21):e14267. doi:10.14814/phy2.14267.
   PubMed Web of Science ®Google Scholar
• Svensson RB, Smith ST, Moyer PJ, Magnusson SP. Effects of maturation and advanced glycation on tensile mechanics of collagen fibrils from rat tail and Achilles tendons. Acta Biomater. 2018;70:270–280. doi:10.1016/j.actbio.2018.02.005.
   PubMed Web of Science ®Google Scholar
• Bailey AJ, Paul RG, Knott L. 1998. Mechanisms of maturation and ageing of collagen. Mech Ageing Dev. 106(1–2):1–56. doi:10.1016/s0047-6374(98)00119-5
   PubMed Web of Science ®Google Scholar
• Sharma U, Carrique L, Vadon-Le Goff S, Mariano N, Georges RN, Delolme F, et al. Structural basis of homo- and heterotrimerization of collagen I. Nat Commun. 2017;8(1):14671. doi:10.1038/ncomms14671.
   PubMed Web of Science ®Google Scholar
• Roschger A, Roschger P, Keplingter P, Klaushofer K, Abdullah S, Kneissel M, et al. Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta. Bone. 2014;66:182–188.
   PubMed Web of Science ®Google Scholar